AzTrials
AzTrials

Lateral EpicondylitisNCT07331337

Scapular Strengthening Exercises in Patients With Chronic Lateral Epicondylitis

A study testing Scapular strengthening and conventional therapy and Conventional Therapy in people with Lateral Epicondylitis, run by King Saud University at 1 site in India.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Lateral epicondylitis is a prevalent musculoskeletal disorder, affecting 1-3% of the population, typically in middle age and without gender bias. Evidence on the role of scapular strengthening in managing pain, grip strength, and functional limitations in these patients remains limited. Read more about this study

Who is it for?
Any age
Conditions the study is for
Lateral Epicondylitis
What is being tested?
Scapular strengthening and conventional therapy and Conventional Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteIndia
Study dates
6 Mar 2020to 23 Oct 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Chronic lateral epicondylitis,
  • Positive Mill's test.

Who cannot join

  • Fracture in the shoulder, wrist, or elbow region,
  • Upper motor neurological disorder,
  • Fibromyalgia,
  • Cervical radiculopathy,
  • Recent burn,
  • Peripheral neuropathy,
  • Any surgery on the upper quadrant within six months.

Trial locations and contacts

1 site in 1 country.

India1 site
  • Cooperative Institute of Health Sciences, Thalassery

    Kannur, Kerala, 670105

Other trials in India

About this study

Official title: Effectiveness of Scapular Strengthening on Pain, Grip Strength, and Function in Chronic Lateral Epicondylitis

Lateral epicondylitis is a prevalent musculoskeletal disorder, affecting 1-3% of the population, typically in middle age and without gender bias. Evidence on the role of scapular strengthening in managing pain, grip strength, and functional limitations in these patients remains limited. This study investigated the impact of scapular muscle strengthening combined with conventional therapy versus conventional therapy alone on these outcomes in individuals with chronic lateral epicondylitis. Thirty participants were randomly assigned to either a control group or an experimental group. Pain was assessed using the visual analogue scale, grip strength with a handheld dynamometer, and functional limitation with the patient-rated tennis elbow (PRTE) scale. The independent variables were the two treatment approaches: conventional therapy alone and conventional therapy supplemented with scapular strengthening.

Being tested
Scapular strengthening and conventional therapy, Conventional Therapy
Keywords
Conventional Therapy, Scapular Strength, Grip Strength, Functional Ability, Pain, Lateral Epicondylitis
Medical subject headings
Tennis Elbow, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Scapular strengthening and conventional therapyOther

    Scapular strengthening, along with conventional therapy that consisted of ultrasound therapy and static stretching.

  • Conventional TherapyOther

    Conventional therapy consisted of ultrasound therapy and static stretching.

Study groups in NCT07331337
Study groupRoleWhat they receive
Scapular StrengtheningExperimentalThe experimental group received scapular strengthening in addition to conventional therapy.
Receives: Other: Scapular strengthening and conventional therapy
Conventional TherapyActive comparatorThe control group received conventional therapy.
Receives: Other: Conventional Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain at elbow

    Pain will be measured using the Visual Analogue Scale. This scale has a minimum value of 0 and a maximum value of 10. A higher score means a worse outcome.

    Measured: 4 weeks

Secondary outcomes (2)
  1. Grip strength

    Grip strength will be measured using a Jamar Hydraulic Hand Dynamometer

    Measured: 4 weeks

  2. Functional difficulty

    Functional difficulty will be measured using the Patient-Reported Tennis Elbow Evaluation (PRTE) scale. This scale ranges from a minimum of 0 (no pain or disability) to a maximum of 100 (worst pain and disability imaginable). A higher score means a worse outcome.

    Measured: 4 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jan 2026
  2. Study start6 Mar 2020
  3. Primary completion17 Sep 2020
  4. Study completion23 Oct 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07331337
Sponsor's protocol ID
IRB-03/MPT-2020/MSK/CIHS
Status last verified
Jan 2026
First submitted
28 Dec 2025
Last updated
12 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Scapular strengthening and conventional therapy and Conventional Therapy in people with Lateral Epicondylitis, run by King Saud University at 1 site in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain at elbow (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in